Are Induced Pluripotent Stem Cells a Step towards Modeling Pediatric Leukemias?

Area of Science:

• Pediatric Hematology
• Stem Cell Biology
• Oncology

Background:

• Acute leukemias remain a significant challenge in pediatric hematology due to high relapse rates and long-term treatment effects.
• Induced pluripotent stem cells (iPSCs) provide a novel technology to model hematological malignancies in vitro.

Purpose of the Study:

• To review the literature on using iPSCs as a model for studying various pediatric hematological malignancies.
• To explore the potential of iPSCs in understanding leukemia onset, development, and clonal evolution.

Main Methods:

• Literature review of studies utilizing iPSCs to model acute myeloid leukemia, non-down syndrome acute megakaryoblastic leukemia, B cell acute lymphoblastic leukemia, and juvenile myelomonocytic leukemia.
• Analysis of iPSC model's impact on understanding fetal hematopoiesis and timing-specific genetic/epigenetic modifications.

Main Results:

• iPSC models effectively reproduce primary features of pediatric leukemias, offering insights into disease mechanisms.
• The model shows promise for studying infant-specific hematological diseases originating from fetal hematopoiesis.
• iPSC applications contribute to understanding clonal evolution and pave the way for precision medicine.

Conclusions:

• iPSCs are a valuable tool for in vitro modeling of pediatric acute leukemias, aiding research into disease origins and development.
• This technology supports the advancement of precision medicine strategies for improved pediatric leukemia treatment outcomes.
• Challenges and limitations associated with the iPSC model in this context are also discussed.